Repeals the excise tax on medical cannabis and the medical cannabis trust fund.
Summary
Bill A04764 seeks to repeal the excise tax imposed on medical cannabis as outlined in section 490 of the New York tax law, as well as the provisions related to the medical cannabis trust fund found in section 89-h of the state finance law. By eliminating these sections, the bill aims to remove the financial burdens associated with the taxation of medical cannabis, potentially making it more accessible to patients who rely on it for medical purposes. The bill is designed to take effect immediately upon passage.
Impact
The repeal of the excise tax on medical cannabis will significantly alter the financial landscape for medical cannabis providers and consumers in New York. It is expected to lower the costs for patients who utilize medical cannabis, thereby increasing access to this form of treatment. Additionally, the dissolution of the medical cannabis trust fund may affect funding allocations previously designated for cannabis-related programs and initiatives, necessitating adjustments in state financial planning and resource distribution.
Sentiment
The general sentiment surrounding Bill A04764 appears to be supportive among advocates for medical cannabis, who argue that the tax repeal will enhance patient access and affordability. However, there may be concerns raised by fiscal conservatives regarding the loss of tax revenue and the implications for state funding related to medical cannabis programs. The absence of recorded votes or committee discussions indicates that the bill's reception remains largely speculative at this stage.
Contention
Notable points of contention may arise from differing perspectives on the financial implications of repealing the excise tax and the trust fund. Supporters, including medical cannabis advocates, emphasize the need for increased access and reduced costs for patients. In contrast, opponents may argue that the repeal could lead to a decrease in state revenue and undermine the financial support for cannabis-related initiatives, raising questions about the long-term sustainability of such programs without the trust fund's resources.
An Act to Institute Testing and Tracking of Medical Use Cannabis and Cannabis Products Similar to Adult Use Cannabis and Cannabis Products, Dedicate a Portion of the Adult Use Cannabis Sales and Excise Tax to Medical Use Cannabis Programs and Create a Study Group
Plant canopy that a medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.
Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision
Enacting the Kansas medical cannabis act to authorize the cultivation, processing, distribution, sale and use of medical cannabis and medical cannabis products.